Listed by the USPTO as ALAM, AYAAN A
Tech Center 1600 • Art Units: 1611 1623
This examiner grants 39% of resolved cases
ALAM, AYAAN A examines in Tech Center 1600 and Art Unit 1611. The docket includes 153 resolved cases and a 38.6% allowance rate. The listed companies are Glatt GmbH, L'Oréal, and Xygenyx Inc., showing activity across industrial, consumer, and biotechnology portfolios.
The interview lift is 36.7%, indicating a meaningful positive association between interviews and allowance outcomes. The median time to allowance is 1208 days, so applicants should prepare for extended prosecution. HAUG PARTNERS LLP, CANTOR COLBURN LLP, and Fox Rothschild LLP are the listed leading firms. Early interview planning and technically focused amendments may be especially useful in this profile.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18956159 | DEVICES AND METHODS FOR REDUCING CYSTINE CRYSTALS IN VIVO | Non-Final OA | University of Florida Research Foundation, Inc. |
| 18035969 | METAL-ORGANIC FRAMEWORK MEDIATED MACROMOLECULE DELIVERY SYSTEM | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 17961142 | SULFATE FREE PERSONAL CLEANSING COMPOSITION COMPRISING LOW INORGANIC SALT AND HYDROXAMIC ACID OR HYDROXAMIC ACID DERIVATIVES | Final Rejection | The Procter & Gamble Company |
| 17785207 | ISOLATED OLEOSOME COMPOSITION AND PROCESS FOR PREPARING IT | Final Rejection | CARGILL, INCORPORATED |
| 18714342 | DIRECT TABLETING AUXILIARY COMPOSITION | Non-Final OA | BASF SE |
| 18409423 | MAGNETIC BIOMOLECULE-METAL ION SELF-ASSEMBLED COMPLEX FOR TREATMENT | Non-Final OA | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 18695455 | COMPOSITIONS FOR USE | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18301616 | Minimum Risk Pesticide Formulations Containing Mineral Oil | Non-Final OA | Henkel AG & Co. KGaA |
| 17592514 | COMPOSITION FOR AEROSOL COSMETICS, AND AEROSOL COSMETICS | Non-Final OA | SHIN-ETSU CHEMICAL CO., LTD. |
| 19033449 | PERSONAL CARE AEROSOL COMPOSITIONS, METHODS AND DEVICES | Non-Final OA | HONEYWELL INTERNATIONAL INC. |
| 18753538 | COMPRESSED TABLETS | Final Rejection | DSM IP Assets B.V. |
| 18527086 | DRUG-ELUTING SUTURE FOR ATTENUATING INFLAMMATION IN WOUNDS | Final Rejection | University of Utah Research Foundation |
| 17150520 | DEGRADABLE MICROPARTICLE, DEGRADABLE PRODUCT COMPRISING THE SAME AND APPLICATION THEREOF | Final Rejection | National Tsing Hua University |
| 18693848 | FOAMING COMPOSITION | Final Rejection | L'OREAL |
| 17757174 | SUN CARE COMPOSITION | Final Rejection | L'OREAL |
| 18976252 | ALTERNATIVE CORROSION INHIBITORS | Non-Final OA | S. C. JOHNSON & SON, INC. |
| 18436539 | DENTAL COMPOSITION | Final Rejection | DENTSPLY SIRONA Inc. |
| 18001382 | ANTIMICROBIAL FORMULATIONS COMPRISING SILICONE | Non-Final OA | AMICOAT AS |
| 18215826 | ARTOCARPUS HETEROPHYLLUS COMPOSITION AND METHOD OF PROMOTING URINARY TRACT HEALTH | Final Rejection | Individual inventor |
| 16985891 | LONG-TERM RE-ABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLED PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE POLYMER SUBSTANCE RELEASE FOR TREATING ENDOMETRIOSIS | Final Rejection | Individual inventor |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy38.6% of resolved applications examined by Ayaan A Alam were allowed (153 resolved cases), compared with 35.4% across Art Unit 1611 over the last five years.
This examiner's interview lift is +36.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ayaan A Alam took 1,208 days on average from filing to allowance.
Ayaan A Alam examines applications in Art Unit 1611 in Tech Center 1600 (Biotechnology & Pharmaceuticals).